^
    8ms
    Study of ZG0895.HCl in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=60, Recruiting, Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Not yet recruiting --> Recruiting | Initiation date: Dec 2023 --> Aug 2023
    Enrollment open • Trial initiation date • Metastases
    |
    ZG0895
    1year
    Study of ZG0895.HCl in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=60, Not yet recruiting, Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Initiation date: Jul 2023 --> Dec 2023
    Trial initiation date • Metastases
    |
    ZG0895
    over1year
    Study of ZG0895.HCl in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=60, Not yet recruiting, Suzhou Zelgen Biopharmaceuticals Co.,Ltd
    New P1 trial • Metastases
    |
    ZG0895